Fumaric Acid

Fumaric Acid

SCHEMBL748371

CN1C2CCC1CC(Nc1ccc(-c3ccc4c(ccn4C)c3)cc1)C2.O=C(O)/C=C/C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 1/20 0.36
CCNC P24863 2/20 0.43
CDK8 P49336 2/20 0.43
FASN P49327 1/20 0.41
KDM4E B2RXH2 1/20 0.41
FAAH O00519 2/20 0.40
CTSC P53634 1/20 0.40
CD274 Q9NZQ7 1/20 0.39
LTA4H P09960 1/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHRNA7 P36544 1/20 0.36
SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL748370 1.00 CCNC (0.43) CCNCCDK8FASNKDM4EFAAH
SCHEMBL745745 0.90 FAAH (0.46) FASNKDM4EFAAHCTSCCD274
SCHEMBL745744 0.90 FAAH (0.46) FASNKDM4EFAAHCTSCCD274
Fumaric Acid SCHEMBL746341 0.81 PTGS2 (0.45) CCNCCDK8FASNKDM4ENPC1
Fumaric Acid SCHEMBL746383 0.81 FFAR1 (0.39) FASNKDM4ELTA4HCHRNA7KCNH2
Fumaric Acid SCHEMBL746382 0.81 FFAR1 (0.39) FASNKDM4ELTA4HCHRNA7KCNH2
Fumaric Acid SCHEMBL746342 0.81 PTGS2 (0.45) CCNCCDK8FASNKDM4ENPC1
Fumaric Acid SCHEMBL989060 0.80 ROCK2 (0.52)
Fumaric Acid SCHEMBL989059 0.80 ROCK2 (0.52)
SCHEMBL747686 0.77 FAAH (0.42) FASNFAAHCTSCCD274NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431368-A1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives Abbott Laboratories (US) 2012-03-21 EP disclosed
EP-2018380-B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LAB (US) 2011-10-19 EP disclosed
US-7872017-B2 Fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LABORATORIES (US) 2011-01-18 US disclosed
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives ABBOTT LABORATORIES (US) 2010-12-02 US disclosed
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES ABBVIE INC. 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES MALT1, BMP2, ALKBH2 KCNH2 708/4885CCNC 49/4885CDK8 439/4885
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives MALT1, BMP2, ALKBH2 KCNH2 708/4885CCNC 49/4885CDK8 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.